A large real-world study in Tianjin, China, found that about 56 percent of patients with both atherosclerotic cardiovascular disease and chronic kidney disease showed systemic inflammation, which was associated with higher risks of major cardiovascular events, death, and healthcare costs.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.